Evidence map›Paper›PMID 42775870›Full record

SynthesisActa dermato-venereologica2026

Photodynamic Diagnosis of Actinic Keratosis: A Systematic Review.

Younes Kazbennaou, Marie Boileau, Cyril Maire, Nadira Delhem, Anne-Sophie Dewalle, Laurent Mortier

Abstract readSystematic Review
In one paragraph

Synthesis in Acta dermato-venereologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Younes KazbennaouDepartment of Dermatology, Claude Huriez Hospital, CHU Lille, Lille, France. younes.kazbennaou@chu-lille.fr.ORCID 0009-0005-5328-3192
Marie BoileauDepartment of Dermatology, Claude Huriez Hospital, CHU Lille, Lille, France; Inserm, CHU Lille, U1189-ONCO-THAI-Assisted Laser Therapy and Immunotherapy for Oncology, University of Lille, Lille, France.
Cyril MaireInserm, CHU Lille, U1189-ONCO-THAI-Assisted Laser Therapy and Immunotherapy for Oncology, University of Lille, Lille, France; St Jean Dermatology clinic, Arras, France.
Nadira DelhemInserm, CHU Lille, U1189-ONCO-THAI-Assisted Laser Therapy and Immunotherapy for Oncology, University of Lille, Lille, France.
Anne-Sophie Dewallenserm, CHU Lille, U1189-ONCO-THAI-Assisted Laser Therapy and Immunotherapy for Oncology, University of Lille, Lille, France.
Laurent MortierDepartment of Dermatology, Claude Huriez Hospital, CHU Lille, Lille, France; nserm, CHU Lille, U1189-ONCO-THAI-Assisted Laser Therapy and Immunotherapy for Oncology, University of Lille, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinic keratosis (AK) is a precancerous condition typically diagnosed by hyperkeratotic papules. The concept of field cancerization suggests subclinical lesions surround visible actinic keratoses. Photodynamic diagnosis (PDD)is a non-invasive imaging modality that can im-prove actinic keratosis diagnosis and treatment assessment. This systematic review describes current evidence regarding photodynamic diagnosis modalities for actinic keratosis. We searched MEDLINE and Embase through 28 February, 2025. Data synthesis was descriptive due to methodological heterogeneity across studies. Thirty-seven studies were included. Methyl aminolevulinate(MAL) and aminolevulinic acid (ALA)were used in 54% and 51% of studies, respectively. Incubation times ranged from 20 to 1080 min, 70 % of studies followed a 3 -h protocol. Most excitation sources (89%) emitted light within the 400-410 nm range, often via clinical-grade systems (54%). Imaging hardware varied: 54 % used integrated clinical systems, 30 % used independent cameras. Fluorescence quantification was described in 62 % of studies, and 54 % used specialized analysis software. Patient positioning was rarely reported (8%). This review highlights significant methodological heterogeneity in actinic keratosis photodynamic diagnosis, particularly in photosensitizer protocols and imaging systems. While clinical-grade systems provide standardization, low-cost alternatives enhance accessibility. However, lack of procedural consistency limits comparability. Future efforts should focus on advancing standardized protocols to support broader clinical validation and adoption.

Indexed as

Aminolevulinic AcidKeratosis, ActinicPhotosensitizing AgentsSkinHumansPredictive Value of TestsAminolevulinic Acidmethyl 5-aminolevulinatePhotosensitizing Agents

Identifiers

PMID42775870
PMCPMC13598950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.